TMS@myhealth101.org

Positive Results from Phase 2a Trial of Psychedelic for Major Depressive Disorder

Jan 25, 2023 Leah Kuntz SPL026 with supportive therapy sees positive results in patients with major depressive disorder. metamorworks/AdobeStock In the first placebo-controlled efficacy study completed to date exploring a short-duration psychedelic for depression, intravenous (IV) N,N-Dimethyltryptamine (DMT)—SPL026—with supportive therapy for the treatment of major depressive disorder (MDD), met the primary endpoint and demonstrated a …

Positive Results from Phase 2a Trial of Psychedelic for Major Depressive Disorder Read More »

What are the differences between the Vielight Neuro Alpha and Neuro Gamma devices?

    What are the differences between the Vielight Neuro Alpha and Neuro Gamma devices? The question, “When should I use an alpha frequency and when should I use a gamma frequency?” is not new. In the context of brain photobiomodulation and Vielight products, this question refers to the Vielight Neuro Alpha and Neuro Gamma …

What are the differences between the Vielight Neuro Alpha and Neuro Gamma devices? Read More »

Common Viruses Could Be Triggering Alzheimer’s Disease Onset

Published: August 1, 2022 | Molly Campbell Varicella zoster virus (VZV), which commonly causes chickenpox and shingles, activates herpes simplex virus (HSV) from dormancy in neural tissue grown in vitro, which then leads to an increase in plaque deposits and decrease in neural signaling – hallmarks of Alzheimer’s disease. Credit: Tufts University.   A new …

Common Viruses Could Be Triggering Alzheimer’s Disease Onset Read More »

Microvascular Dysfunction in COVID-19 Patients: MYSTIC Study

Microvascular Dysfunction in COVID-19 Patients: MYSTIC Study   ALPINE, Utah, Oct. 30, 2020 /PRNewswire/ — Research reveals that COVID-19 patients have severe damage to microcirculation and the endothelial glycocalyx. The data in a newly released study clearly show severe reduction of microcirculation and the endothelial glycocalyx in patients with COVID-19 and underscores the importance of healthy microcirculation …

Microvascular Dysfunction in COVID-19 Patients: MYSTIC Study Read More »

Managing Depression as an Inflammatory Condition

Managing Depression as an Inflammatory Condition Lylen Ferris, ND | March 17, 2021 Patients with major depression have been found to exhibit increased peripheral blood inflammatory biomarkers, including inflammatory cytokines. Cytokines have been shown to access the brain and interact with virtually every pathophysiologic domain known to be involved in depression, including neurotransmitter synthesis and metabolism, neuroendocrine function, and neural plasticity. A …

Managing Depression as an Inflammatory Condition Read More »

Alzheimer’s Pathology Linked to Diet

Can a certain variety of foods slow Alzheimer’s progression?     by Judy George, Senior Staff Writer, MedPage  May 6, 2021 https://www.medpagetoday.com/neurology/alzheimersdisease/92460   People who followed a Mediterranean-style diet closely had less amyloid and tau pathology, increased brain volume in regions vulnerable to Alzheimer’s disease, and better memory performance, a cross-sectional analysis in Germany showed. Higher …

Alzheimer’s Pathology Linked to Diet Read More »

This Mineral Is Probably Making Your Chronic Stress and Anxiety Worse

I suffered from anxiety for years. It runs in my family. Many of my cousins, aunts, uncles and grandparents suffer from anxiety and depression and have relied on alcohol, nicotine, and anti-depressant and anti-anxiety medication to manage it. I didn’t want to go down that path, so I’ve sought out other treatments for years. Unfortunately, …

This Mineral Is Probably Making Your Chronic Stress and Anxiety Worse Read More »